Related Experiment Video

Updated: Aug 24, 2026

In vivo Imaging and Therapeutic Treatments in an Orthotopic Mouse Model of Ovarian Cancer
07:46

In vivo Imaging and Therapeutic Treatments in an Orthotopic Mouse Model of Ovarian Cancer

Published on: August 17, 2010

Vaccination as a treatment for breast or ovarian cancer

Leona A Holmberg1, Brenda Sandmaier

  • 1Department of Medicine, University of Washington School of Medicine, and Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA. lholmber@fhcrc.org

Expert Review of Vaccines
|June 5, 2004
PubMed

Insights

The immune system can identify breast and ovarian cancer cells, but its effectiveness in controlling these cancers requires further proof. Successful cancer vaccines must overcome immune tolerance and inhibitory mechanisms to effectively target tumor antigens.

Area of Science:

  • Immunology
  • Oncology
  • Vaccinology

Background:

  • The immune system's role in recognizing breast and ovarian cancer cells is established.
  • The clinical effectiveness of the immune system in controlling these cancers remains unproven.
  • Breaking immune tolerance is crucial for effective cancer immunotherapy.

Purpose of the Study:

  • To explore strategies for enhancing the immune system's ability to control breast and ovarian cancers.
  • To address the challenges in developing effective cancer vaccines.
  • To investigate methods for overcoming immune tolerance in cancer patients.

Main Methods:

  • Review of current understanding of anti-tumor immunity in breast and ovarian cancers.
  • Analysis of challenges in cancer vaccine development.
  • Exploration of immune evasion mechanisms employed by tumors.

Main Results:

  • The immune system recognizes cancer cells, but its efficacy in controlling tumor growth is not definitively proven.
  • Vaccination strategies face the hurdle of breaking immune tolerance.
  • Successful vaccine development hinges on identifying suitable tumor antigens and effective immunization approaches.

Conclusions:

  • Further research is needed to validate the immune system's efficacy against breast and ovarian cancers.
  • Overcoming immune tolerance is a key challenge for cancer vaccine development.
  • Effective cancer vaccines require strategic antigen selection and methods to circumvent immune suppression.

More Related Videos

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose13:04

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose

Published on: October 14, 2015

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...